BGC > Product Search > n-[2-[[4-(diethylamino)butyl]amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)urea | 219580-11-7

Molecular Formula: C28H41N7O3
Molecular Weight: 523.678
Hazard Symbols: Xi
WGKGermany: 3

Molecular Formula: C28H41N7O3
Molecular Weight: 523.678
Hazard Symbols: Xi
WGKGermany: 3

Molecular Formula: C28H41N7O3
Molecular Weight: 523.678
Hazard Symbols: Xi
WGKGermany: 3

Description :
PD173074 is a small-molecule FGFR3-selective tyrosine kinase inhibitor (TKI), as a therapeutic modality using eight UC cell lines. PD173074 suppressed cell proliferation remarkably in two cell lines, namely, UM-UC-14 and MGHU3, which expressed mutated FGFR3 protein. Cell cycle analysis revealed the growth inhibitory effect of PD173074 was associated with arrest at G(1)-S transition in a dose-depending manner. In the mouse xenograft models using subcutaneously transplanted UM-UC-14 and MGHU3, orally administered PD173074 suppressed tumor growth and induced apoptotic changes comparable with the results of our in vitro assay. These findings elucidated the effectiveness of molecular targeted approach for bladder UC harboring FGFR3 mutations and the potential utility to decrease the intravesical recurrence of nonmuscle invasive bladder UC after transurethral surgical resection.

• Molecular Weight :523.682
• Purity :0.98

Molecular Formula :
C28H41N7O3
Canonical SMILES :
CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C
InChI :
InChI=1S/C28H41N7O3/c1-8-35(9-2)13-11-10-12-29-26-30-18-20-16-23(19-14-21(37-6)17-22(15-19)38-7)25(31-24(20)32-26)33-27(36)34-28(3,4)5/h14-18H,8-13H2,1-7H3,(H3,29,30,31,32,33,34,36)
InChIKey :
DXCUKNQANPLTEJ-UHFFFAOYSA-N
Appearance :
Yellow solid
Application :
Differentiation, Self-Renewal
Synonyms :
PD173074; PD 173074; PD-173074.

More details are to be found here